Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Microbiotic Product (NBT-NM108) to Promote Microbiome Health and Improve Chemotherapy Delivery

NCT05296681 is registered in ClinicalTrials.gov with Howard S. Hochster, MD as lead sponsor.

NCT NCT05296681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05296681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Microbiotic Product (NBT-NM108) to Promote Microbiome Health and Improve Chemotherapy Delivery
Lead sponsor
Howard S. Hochster, MD
Phase
Phase 2
Overall status
Recruiting
Start date
May 3, 2022
Completion date
June 1, 2027
Enrollment
42 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colon carcinoma, stage iv colon cancer ajcc v8, stage iva colon cancer ajcc v8, stage ivb colon cancer ajcc v8, stage ivc colon cancer ajcc v8